Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-23 · accession 0001127602-23-019405 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-26 | 2023-06-23+ | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $2.34 | +20.0K | 804.4K | +3% | +$46.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-23 | P | A | 10,000 | $2.50 | 794,359 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-26 | P | A | 10,000 | $2.18 | 804,359 | D | — | — |